Status:
COMPLETED
Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients
Lead Sponsor:
Vincenzo Cannizzaro
Conditions:
Arterial Hypotension in Critically Ill Neonatal and Pediatric Patients
Eligibility:
All Genders
Up to 17 years
Brief Summary
Blood copeptin will be measured during the routine treatment of neonates, children and adolescents on the Intensive Care Unit of the University Children's Hospital Zurich at different time points (adm...
Eligibility Criteria
Inclusion
- Age: first day of life until 18th birthday.
- Ability of the care taker or the adolescent (if≥14 years of age) to understand verbal and written instructions and informed consent in German.
Exclusion
- Care taker or adolescent (if ≥14 years of age) unwilling to give written informed consent.
- Care taker or adolescent (if ≥14 years of age) not understanding German and without a family member able to translate.
- Adolescent (if ≥14 years of age) unwilling to give written informed consent following sedation \< 24 hours.
- Care takers of long-term sedated (\>24 hours) adolescents (if ≥14 years of age) unwilling to give written informed consent or not present within 24 hours.
Key Trial Info
Start Date :
December 4 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT03320967
Start Date
December 4 2017
End Date
June 30 2019
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Zurich
Zurich, Switzerland, 8032